QIAGEN is a provider of sample preparation and molecular diagnostic and research assay technologies used in life sciences, clinical, and applied testing markets.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| TOMS Capital Investment Management LP (auto-surfaced) | 69 | New buy | 1,500,000 | $60,060,000 | 1.6% |
| Louis Bacon / Moore | 56 | New buy | 20,000 | $800,800 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.